358 related articles for article (PubMed ID: 12502945)
1. Activity of voriconazole against corneal isolates of Scedosporium apiospermum.
Shah KB; Wu TG; Wilhelmus KR; Jones DB
Cornea; 2003 Jan; 22(1):33-6. PubMed ID: 12502945
[TBL] [Abstract][Full Text] [Related]
2. [Fungal keratitis caused by Scedosporium apiospermum: first report from Turkey].
Kalkan Akçay E; Açıkgöz ZC; Can ME; Celikbilek N; Dereli Can G; Cağıl N
Mikrobiyol Bul; 2013 Oct; 47(4):727-33. PubMed ID: 24237443
[TBL] [Abstract][Full Text] [Related]
3. Scedosporium apiospermum keratitis treated with itraconazole.
Saracli MA; Erdem U; Gonlum A; Yildiran ST
Med Mycol; 2003 Apr; 41(2):111-4. PubMed ID: 12964842
[TBL] [Abstract][Full Text] [Related]
4. Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
Ann Pharmacother; 2009 Jun; 43(6):1139-42. PubMed ID: 19435962
[TBL] [Abstract][Full Text] [Related]
5. [Fungal keratitis caused by Scedosporium apiospermum].
Ponchel C; Cassaing S; Linas MD; Arné JL; Fournié P
J Fr Ophtalmol; 2007 Nov; 30(9):933-7. PubMed ID: 18046279
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal voriconazole for the treatment of endogenous endophthalmitis caused by Scedosporium apiospermum.
Chen FK; Chen SD; Tay-Kearney ML
Clin Exp Ophthalmol; 2007; 35(4):382-5. PubMed ID: 17539796
[TBL] [Abstract][Full Text] [Related]
7. Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs.
Capilla J; Guarro J
Antimicrob Agents Chemother; 2004 Oct; 48(10):4009-11. PubMed ID: 15388467
[TBL] [Abstract][Full Text] [Related]
8. Scedosporium apiospermum traumatic endophthalmitis successfully treated with voriconazole.
Zarkovic A; Guest S
Int Ophthalmol; 2007 Dec; 27(6):391-4. PubMed ID: 17901927
[TBL] [Abstract][Full Text] [Related]
9. [Fungal keratitis caused by Scedosporium apiospermum: first report from Turkey-comment].
Atalay MA; Koc AN
Mikrobiyol Bul; 2014 Apr; 48(2):362-3. PubMed ID: 24819276
[TBL] [Abstract][Full Text] [Related]
10. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.
Cuenca-Estrella M; Ruiz-Díez B; Martínez-Suárez JV; Monzón A; Rodríguez-Tudela JL
J Antimicrob Chemother; 1999 Jan; 43(1):149-51. PubMed ID: 10381115
[TBL] [Abstract][Full Text] [Related]
11. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy.
Muñoz P; Marín M; Tornero P; Martín Rabadán P; Rodríguez-Creixéms M; Bouza E
Clin Infect Dis; 2000 Dec; 31(6):1499-501. PubMed ID: 11096022
[TBL] [Abstract][Full Text] [Related]
12. Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis.
Borghi E; Iatta R; Manca A; Montagna MT; Morace G
Med Mycol; 2010 Nov; 48 Suppl 1():S108-13. PubMed ID: 21067322
[TBL] [Abstract][Full Text] [Related]
13. Endogenous Scedosporium apiospermum endophthalmitis.
Jain A; Egbert P; McCulley TJ; Blumenkranz MS; Moshfeghi DM
Arch Ophthalmol; 2007 Sep; 125(9):1286-9. PubMed ID: 17846376
[No Abstract] [Full Text] [Related]
14. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
Marangon FB; Miller D; Giaconi JA; Alfonso EC
Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
[TBL] [Abstract][Full Text] [Related]
15. Mycotic keratitis caused by Scedosporium apiospermum in an immunocompetent patient.
Galvis V; Berrospi R; Tello A; Ramírez D; Villarreal D
Arch Soc Esp Oftalmol (Engl Ed); 2018 Dec; 93(12):613-616. PubMed ID: 30017419
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of conventional antifungal agents against Scedosporium apiospermum isolates recovered from clinical and environmental samples in Nigeria.
Nweze EI; Okafor JI
Acta Microbiol Immunol Hung; 2010 Sep; 57(3):209-14. PubMed ID: 20870592
[TBL] [Abstract][Full Text] [Related]
17. Use of voriconazole in Scedosporium apiospermum keratitis.
Lai TF; Malhotra R; Esmail-Zaden R; Galanopoulas A; Chehade M; Selva D
Cornea; 2003 May; 22(4):391; discussion 391-2. PubMed ID: 12792490
[No Abstract] [Full Text] [Related]
18. Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia.
Beier F; Kittan N; Holzmann T; Schardt K; Andreesen R; Holler E; Hildebrandt GC
Transpl Infect Dis; 2010 Dec; 12(6):538-42. PubMed ID: 20604906
[TBL] [Abstract][Full Text] [Related]
19. Case of cutaneous Scedosporium apiospermum infection successfully treated with voriconazole.
Matsumoto Y; Oh-I T; Nagai A; Ohyama F; Ooishi T; Tsuboi R
J Dermatol; 2009 Feb; 36(2):98-102. PubMed ID: 19284454
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents.
Zeng J; Kamei K; Zheng Y; Nishimura K
Nihon Ishinkin Gakkai Zasshi; 2004; 45(2):101-4. PubMed ID: 15118667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
